RGS antibody (N-Term)
Quick Overview for RGS antibody (N-Term) (ABIN630222)
Target
See all RGS AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- RGS9 antibody was raised against the N terminal of RGS9
-
Purification
- Purified
-
Immunogen
- RGS9 antibody was raised using the N terminal of RGS9 corresponding to a region with amino acids MYYQQALMRSTVKSSVSLGGIVKYSEQFSSNDAIMSGCLPSNPWITDDTQ
-
-
-
-
Application Notes
-
WB: 2 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
RGS9 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this RGS9 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RGS9 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- RGS (Regulator of G-Protein Signaling 9 (RGS))
-
Alternative Name
- RGS9
-
Background
- RGS9 is a member of the RGS family of signaling proteins that suppress the activity of G proteins by promoting their deactivation.
-
Molecular Weight
- 49 kDa (MW of target protein)
-
Pathways
- Myometrial Relaxation and Contraction, Regulation of G-Protein Coupled Receptor Protein Signaling, Phototransduction
Target
-